SWOG clinical trial number
SWOG-7438
Cis-Diamminedichloroplatinum (II)(NSC-119875, CACP) for Malignancies of the Gynecologic and Genitourinary Organs
Closed
Abbreviated Title
Cis-Diamminedichloroplatinum (II)(NSC-119875, CACP) for Malignancies of the Gynecologic and Genitourinary Organs
Activated
01/09/1975
Closed
01/26/1977
Publication Information Expand/Collapse
1979
Phase II evaluation of cis-dichlorodiammineplatinum (II) in advanced malignancies of the genitourinary and gynecologic organs: A Southwest Oncology Group study.
Phase II evaluation of cis-dichlorodiammineplatinum (II) in advanced malignancies of the genitourinary and gynecologic organs: A Southwest Oncology Group study.
1977
Phase II evaluation of single high-dose cis-diamminedi- chloroplatinum (II) (NSC-119875, CACP) in gynecologic *GYN) and genitourinary (GU) neoplasia.
Phase II evaluation of single high-dose cis-diamminedi- chloroplatinum (II) (NSC-119875, CACP) in gynecologic *GYN) and genitourinary (GU) neoplasia.